Stratified analysis of the association between GDM and abdominal circumference (AC) >90th percentile at 28 wkGA. Stratified analysis of the association.

Slides:



Advertisements
Similar presentations
GESTATIONAL DIABETES FORUM 28/5/14. Hyperglycemia in Pregnancy Gestational Diabetes Mellitus Is GDM important? How should we screen for it? Does treatment.
Advertisements

Diabetes in Pregnancy Screening.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
A medical test to determine the ability of an individual to maintain HOMEOSTASIS of Blood Glucose The most commonly performed version of the Test (OGTT)
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Type 2 Diabetes- Treatment Toolbox by: Karen L. Staples, FNP, ACNP Where Do I Start?
Prevention of Type 2 Diabetes. Hyperglycemia in Type 2 Diabetes: Changing Treatment Paradigms.
TEMPLATE DESIGN © PREDICTIVE FACTORS OF ABNORMAL GLUCOSE TOLERANCE AT 6 WEEKS POST PARTUM IN WOMEN WITH GESTATIONAL DIABETES.
Gestational Diabetes Testing Paradigms in a Rural Office November 7, 2014.
GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.
IDC 1.1 Global and National Burden of Diabetes Diabetes Mellitus: classification New (WHO) Screening and Diagnostic Criteria –Diabetes, Impaired Glucose.
MATERIAL & METHODS SECTION PREPARATION (IN THE HEALTH RESEARCH PROPOSAL) DR. HAYFAA A. WAHBI ASSISTANT PROFESSOR, CHAIR OF EBHC & KT COLLEGE OF MEDICINE.
The Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal Overgrowth.
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
Identify the risk factors, diagnosis and prevalence of diabetes in the United States. Describe the function of the pancreas, the intestines and liver.
©1999, Medical Age Publishing, Division of Snyder Healthcare Communications Worldwide, Stamford, Connecticut. All rights reserved. Epidemiology and Diagnosis.
Gestational Diabetes Gestational Diabetes. Definition Any degree of glucose intolerance with onset or 1 st recognition during pregnancy. Any degree of.
Diabetes Prevention Program (DPP)
Diabetes in Pregnancy Diabetes: a leading complication in pregnancy Forms of diabetes include: –Type 1 diabetes—Results from destruction of insulin-producing.
Diabetes. Objectives: Diabetes Mellitus (DM) Discuss the prevalence of diabetes in the U.S. Contrast the main types of diabetes. Describe the classic.
CHANGES in ada 2015.
Screening for Diabetes in Pregnancy
Insulin Resistance and serum Leptin levels in women with Gestational Diabetes Mellitus GÖKÇE ANIK İLHAN Yasemin Emiroğlu Çekiç1, Gökçe Anık İlhan2, Kadir.
From: United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients.
American Public Health Association Annual Meeting
A Study on Gestational Diabetes in Eastern India
The effect of metformin treatment of GDM-patients
L. Bozkurt1, C. S. Göbl2 , A.-T. Hörmayer1, Anton Luger1, Sabina Baumgartner-Parzer1, A. Kautzky-Willer1 Implications of pregestational overweight.
Case studies In this presentation we will review hypoglycaemia – the causes, signs and symptoms, treatment, and prevention. We will also discuss unawareness.
Capacity Building for Prevention of Complication from Gestational Diabetes in Public health system, UP Dr Rajesh Jain Project Manager Diabetes Prevention.
Screening for Diabetes in Pregnancy
A randomized controlled trial of a web-based education intervention for women with gestational diabetes mellitus  Mary Carolan-Olah, Padaphet Sayakhot 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Level of risk factor control in the overall sample and by gender
ROGER S. MAZZE, Ph.D., CHRISTOPHER L. KROGH, M.D. 
Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6
Persistent organic pollutants and diabetes - Spearman correlation coefficients* among six POPs with age, sex, race and ethnicity, poverty income.
Diabetes and Pregnancy
Incidence of diabetes over time depends on GIS
Trends in prevalence of diabetes in middle-aged women grouped according to BMI at the first survey of the ALSWH. ▪, healthy (n = 5,252); ♦, overweight.
A: Relative risk of experiencing one or more hypoglycemic events per participant at any time (24 h) and during the night (0000–0559 h) for Gla-300 vs.
Glucose, insulin, and AGE levels during an OGC before and after RT
Prevalence of high SAT or high VAT by BMI category in women (A) and men (B) and by waist circumference category in women (C) and men (D). Prevalence of.
Comparison of women carrying a male fetus and those carrying a female fetus, with respect to mean adjusted blood glucose levels during the OGTT (A), mean.
Insulin sensitivity in athletes and sedentary normal-weight and obese, young, and old individuals. Insulin sensitivity in athletes and sedentary normal-weight.
Adjusted HRs (95% CIs) for all-cause mortality associated with BMI by smoking status in men and women and by CHD, type 2 diabetes, and cancer status at.
Adjusted HRs (95% CIs) for all-cause mortality associated with body fat percentage by smoking status in men and women and by CHD, type 2 diabetes, and.
Effects of Rosi treatment on ASKO mice.
Yield of abnormal glucose tolerance in 30,383 people screened by the DPP who underwent OGTT by sex, age, BMI, family history of diabetes, and ethnicity.
Dr. Hayfaa A. Wahbi ASSociate professor, Chair of EBHC & KT
Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.
Interaction of leg length on the association of waist circumference with measures of insulin sensitivity, adjusted for sex, ethnicity, and age. Interaction.
Adjusted ORs for pregravid, antepartum, and postpartum factors as predictors of likelihood that a woman will gain weight between 3 and 12 months postpartum.
Mean adjusted levels in each group for the following cardiometabolic risk factors at 3 and 12 months postpartum: (A) systolic blood pressure, (B) diastolic.
Glycemic control and body weight over 52 weeks.
Difference in average school grades between offspring born to women with type 1 diabetes and the matched control children, by maternal third trimester.
Effects of vinegar (□) and placebo (⧫) on plasma glucose (A–C) and insulin (D–F) responses after a standard meal in control subjects, insulin-resistant.
Correlations between leptin DNA methylation and 2-h post-OGTT glucose levels, within the IGT group (A and B), leptin DNA methylation and mRNA levels (C.
A: Probability of SICH by baseline glucose level.
Clinical responses to therapy from baseline to week 24 and end point with last observation carried forward (LOCF). Clinical responses to therapy from baseline.
Example of how quantitative variables displaying a nonhomogeneous risk in visual display were split in high- and low-risk categories. Example of how quantitative.
Adjusted OR and SE for BMI≥30 kg/m2, BMI 25–29. 9 kg/m2, HbA1c≥6
Spearman rank order correlation between suppression of hepatic glucose production with low insulin infusion and 30-min change in glucose response in women.
Effects of PCSK7 rs genotype and CHO diets on changes and reversion in fasting insulin levels and HOMA-IR during the 2-year intervention in white.
Glycemic profile at time of recruitment of women with ICP (n = 19) and uncomplicated pregnancy (n = 23) using a CGMS (Medtronic iPro2) over 3 days. Glycemic.
Risk of mortality in patients with diabetes and ESRD
Cumulative distributions of A1C and fasting plasma glucose values for the U.S. population aged ≥12 years without diabetes for each survey cycle: 1999–2000,
Cumulative mean numbers of confirmed (plasma glucose ≤3
Presentation transcript:

Stratified analysis of the association between GDM and abdominal circumference (AC) >90th percentile at 28 wkGA. Stratified analysis of the association between GDM and abdominal circumference (AC) >90th percentile at 28 wkGA. Points are adjusted relative risks, and bars are 95% CI. Stratification was by obesity (BMI ≥30 kg/m2), GDM treatment type (diet only or medication [insulin or metformin]), and year of the 28 wkGA scan (2008–2010 diagnoses were based on a modified version of the 1999 WHO criteria: fasting, 1-h, and 2-h glucose levels >6.1 mmol/L [110 mg/dL], 10.0 mmol/L [180 mg/dL], or 7.8 mmol/L [140 mg/dL], respectively, and 2011–2012 diagnoses were based on the modified IADPSG criteria: thresholds 5.3 mmol/L [95 mg/dL], 10.0 mmol/L [180 mg/dL], or 8.5 mmol/L [153 mg/dL], respectively). One hundred sixteen women had a diagnosis of GDM in the pregnancy, attended for a 75-g fasting OGTT at ∼6 weeks postpartum, and had a normal result (fasting glucose <6.1 [110 mg/dL] and a 2-h glucose <7.8 mmol/L [140 mg/dL]). Analyses were adjusted for the year of the 28 wkGA scan, maternal age, height, ethnicity (Indian/Pakistani/Bangladeshi vs. others), weight gain, and BMI, as appropriate (where the analysis was not stratified by the respective variable). GTT, glucose tolerance test. Ulla Sovio et al. Dia Care 2016;39:982-987 ©2016 by American Diabetes Association